Use of a Radiopaque Localizer Grid and Methylene Blue Staining as an Aid to Reduce Radiation Exposure

Localization of small femur lesions for resection can be challenging and may be associated with the need for significant fluoroscopic imaging and tissue dissection.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Bone Diseases Musculoskeletal Diseases

Age range

4 year–9 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

This study was performed to evaluate the use of a radiopaque localizer grid along with methylene blue staining for resection of small femur lesions in children, and to determine this technique's effectiveness at reducing radiation exposure and tissue injury.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients with lesions <20.0 mm

Exclusion criteria

patients with lesions >20.0 mm

Treatment and study plan

surgical treatment

Radiation

Use of a radiopaque localizer grid and methylene blue staining as an aid to resect the lesions

Primary outcomes

The times of C-arm fluoroscopy used

Time frame: intraoperative

Secondary outcomes

incision length

Time frame: intraoperative

Sponsors and collaborators

Lead sponsor

Children's Hospital of Chongqing Medical University

Other

Registry information

Official study title

Use of a Radiopaque Localizer Grid and Methylene Blue Staining as an Aid to Reduce Radiation Exposure in Resection Small Femur Lesions

Important dates

Study start: 2010
Primary completion: 2015
Study completion: 2015
First posted: Nov 21, 2016
Registry last updated: Nov 25, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed